We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Eli Lilly
LLY
$1.05T
| $173M | 0.33% |
221,781
-76,672
| -26% | -$59.6M |
2013 Q2
48 quarters
|
|
77
Emcor
EME
$34.8B
| $172M | 0.32% |
322,437
+116,289
| +56% | +$51.3M |
2014 Q3
43 quarters
|
|
78
Intuitive Surgical
ISRG
$150B
| $170M | 0.32% |
313,035
-9,678
| -3% | -$5.06M |
2013 Q2
48 quarters
|
|
79
Vistra
VST
$54.2B
| $169M | 0.32% |
871,520
+481,522
| +123% | +$71.3M |
2018 Q1
29 quarters
|
|
80
Shopify
SHOP
$220B
| $167M | 0.31% |
1,443,505
-4,262
| -0.3% | -$426K |
2015 Q2
40 quarters
|
|
81
British American Tobacco
BTI
$119B
| $165M | 0.31% |
3,476,001
+3,315,589
| +2,067% | +$147M |
2013 Q2
48 quarters
|
|
82
GoDaddy
GDDY
$13.2B
| $164M | 0.31% |
909,518
-88,140
| -9% | -$15.8M |
2022 Q2
12 quarters
|
|
83
HEICO Corp
HEI
$41.7B
| $163M | 0.31% |
495,935
-4,564
| -0.9% | -$1.26M |
2017 Q1
33 quarters
|
|
84
JPMorgan Chase
JPM
$885B
| $162M | 0.3% |
557,654
-76,350
| -12% | -$19.5M |
2013 Q2
48 quarters
|
|
85
Comfort Systems
FIX
$60.4B
| $160M | 0.3% |
297,944
-1,989
| -0.7% | -$866K |
2015 Q2
40 quarters
|
|
86
Wingstop
WING
$3.33B
| $158M | 0.3% |
469,762
-47,025
| -9% | -$13.9M |
2015 Q2
40 quarters
|
|
87
TJX Companies
TJX
$153B
| $155M | 0.29% |
1,257,482
+53,647
| +4% | +$6.8M |
2013 Q2
48 quarters
|
|
88
Realty Income
O
$51.3B
| $154M | 0.29% |
2,669,031
+309,902
| +13% | +$17.5M |
2013 Q2
48 quarters
|
|
89
JD.com
JD
$36.6B
| $149M | 0.28% |
4,551,070
+177,000
| +4% | +$6.04M |
2017 Q2
32 quarters
|
|
90
Cardinal Health
CAH
$55B
| $148M | 0.28% |
878,986
+88,345
| +11% | +$13.1M |
2013 Q2
48 quarters
|
|
91
Allison Transmission
ALSN
$9.07B
| $147M | 0.28% |
1,544,799
+406,540
| +36% | +$39.3M |
2015 Q3
39 quarters
|
|
92
Maplebear
CART
$11.3B
| $144M | 0.27% |
3,179,537
+347,153
| +12% | +$15.1M |
2023 Q3
7 quarters
|
|
93
Loar Holdings
LOAR
$5.82B
| $142M | 0.27% |
1,649,069
+512,416
| +45% | +$44.3M |
2024 Q2
4 quarters
|
|
94
Tyler Technologies
TYL
$13.5B
| $141M | 0.26% |
237,134
+15,452
| +7% | +$8.75M |
2013 Q2
48 quarters
|
|
95
TSMC
TSM
$2.35T
| $141M | 0.26% |
620,522
+19,696
| +3% | +$3.65M |
2018 Q3
27 quarters
|
|
96
Progressive
PGR
$126B
| $140M | 0.26% |
524,532
+266,919
| +104% | +$73.2M |
2013 Q2
48 quarters
|
|
97
LyondellBasell Industries
LYB
$19.4B
| $140M | 0.26% |
2,414,745
-2,329,494
| -49% | -$136M |
2013 Q2
48 quarters
|
|
98
Duolingo
DUOL
$7.01B
| $140M | 0.26% |
340,444
+89,061
| +35% | +$39.1M |
2023 Q1
9 quarters
|
|
99
TC Energy
TRP
$62.6B
| $140M | 0.26% |
2,860,729
+28,572
| +1% | +$1.4M |
2015 Q1
41 quarters
|
|
100
GSK
GSK
$93.2B
| $139M | 0.26% |
3,632,471
+3,494,657
| +2,536% | +$134M |
2023 Q2
8 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.